
Innovative drug arm of CSPC Pharmaceutical Group, the Chinese pharmaceutical group headquartered in Shijiazhuang, Hebei and listed in Hong Kong under code 1093. NBP Pharmaceutical manufactures and markets butylphthalide, sold as NBP, a Chinese class 1 innovative drug for acute ischaemic stroke available as soft capsules and injection, together with other central nervous system and cardiovascular products, and runs the group's innovative drug commercialisation in these areas.
Leave your rating